Skip to main content
FinSpry Logo
FinSpry
ZYBT logo
ZYBT
(NASDAQ)
Zhengye Biotechnology Holding Limited
$0.88-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Zhengye Biotechnology Holding (ZYBT) Stock Price & Financial Analysis

Zhengye Biotechnology Holding Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.85 - $0.88
52-Week High$14.30
52-Week Low$0.68
Open$0.85
Volume17.77K
Average Volume (3M)17.77K
Market Cap47.64M
Shares Outstanding47.17M
P/E Ratio (TTM)29.00
Price to Sales (P/S)1.76
Price to Book (P/B)1.10
EV/EBITDA8.64
Revenue (TTM)27.07M
Net Income (TTM)1.64M
Free Cash Flow (TTM)1.93M
EPS (TTM)$0.03
Profit Margin6.07%
Operating Margin8.82%
Return on Equity (ROE)3.78%
Debt to Equity0.29
50-Day MA$0.89
200-Day MA$3.59
52-Week Change-82.96%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Zhengye Biotechnology Holding

What is the current stock price for ZYBT?

As of the latest trading session, ZYBT stock trades at $0.88. The 52-week range is $0.68–$14.30, with a day range of $0.85–$0.88.

What is the P/E ratio for ZYBT?

Zhengye Biotechnology Holding's trailing P/E ratio is 29.0, meaning investors pay $29.0 for every $1 of annual earnings. Zhengye Biotechnology Holding operates in the Healthcare sector.

Does ZYBT pay dividends?

Zhengye Biotechnology Holding does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ZYBT?

Analyst ratings and recommendations for ZYBT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ZYBT?

Zhengye Biotechnology Holding's market capitalization is $41.5M, classifying it as a micro-cap company. Zhengye Biotechnology Holding operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.